Haima is a pre-clinical stage biotechnology company in Cleveland, OH. We are developing platelet inspired therapeutics to control bleeding and to treat other blood-related disorders where platelet play a key role in its progression, such as thrombosis, inflammation, cancer metastasis and other pathologies. Our lead program focuses on developing a novel treatment of active bleeding and bleeding risks.